Millennium Management
INBX

Millennium Management’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Millennium Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-25,110
Closed -$878K – 6803
2024
Q1 		$878K Sell
25,110
-235,948
-90% -$8.6M ﹤0.01% 4415
2023
Q4 		$9.92M Buy
261,058
+228,730
+708% +$4.9M ﹤0.01% 2193
2023
Q3 		$593K Sell
32,328
-148,020
-82% -$3.1M ﹤0.01% 4549
2023
Q2 		$4.68M Sell
180,348
-539,205
-75% -$12.6M ﹤0.01% 2738
2023
Q1 		$13.6M Buy
719,553
+21,717
+3% +$505K 0.01% 1674
2022
Q4 		$17.2M Buy
697,836
+201,410
+41% +$5.92M 0.01% 1579
2022
Q3 		$8.91M Sell
496,426
-450,605
-48% -$8.12M 0.01% 2284
2022
Q2 		$10.7M Buy
+947,031
New +$13.9M 0.01% 1949
2021
Q4 		– Sell
-49,634
Closed -$1.65M – 7908
2021
Q3 		$1.65M Sell
49,634
-267,767
-84% -$8.15M ﹤0.01% 4132
2021
Q2 		$8.73M Buy
317,401
+234,383
+282% +$4.88M 0.01% 2081
2021
Q1 		$1.67M Buy
83,018
+10,714
+15% +$313K ﹤0.01% 3707
2020
Q4 		$2.38M Buy
72,304
+4,628
+7% +$123K ﹤0.01% 3103
2020
Q3 		$1.22K Buy
+67,676
New +$1.23M ﹤0.01% 2999

Other funds holding INBX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Millennium Management's INBX Position: Q2 2024 in Review

Millennium Management sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 25,110 shares — an estimated $878K sold.

Millennium Management first reported a position in INBX in Q3 2020 and held it in 13 quarters. The position peaked at $17.2M in Q4 2022. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

  • Millennium Management reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Millennium Management sold 25,110 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $878K.
  • Millennium Management first reported a position in Inhibrx, Inc. Common Stock in Q3 2020 and held it in 13 quarters.
  • Millennium Management's Inhibrx, Inc. Common Stock position peaked at $17.2M in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Millennium Management's 13F filing for Q2 2024, filed 14 Aug 2024.